Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
Remote Monitored Systems (LON: RMS) shares are surging on Friday morning after the company noted the press release by the British High Commission regarding its Anglo-Indian partnership to distribute its MHRA approved Pro-Larva mask in India.
The British High Commission said it was “delighted to announce a new Anglo-Indian partnership between British technology firm Pharm 2 Farm Limited, a subsidiary of nanosynth group plc, and India's VKE Enterprises to distribute British MHRA approved Pro-Larva mask.”
RMS announced in June that it is planning to change its name to Nanosynth Group.
The Pro-Larva Face Mask is made in Britain using α-Virion nanotechnology that is “clinically approved to kill 99.9% of Covid and Influenza viruses, within 5 minutes of contact, and continues to kill the virus for seven hours.”
British inventor and director of RMS (Nanosynth), Dr Gareth Cave, said: “The mask we've developed has been proven to inactivate viruses upon contact; the antiviral layer kills virus which has been blocked by the filter layers. The challenge with conventional surgical-type masks is that they only block virus from entering or exiting the mask. They don't have an active mechanism for killing it once it's trapped in the mask.
“Our new antiviral mask has been designed to utilise the existing barrier technology and combine it with our nanotechnology to kill the virus once it is trapped there.
“We've added the barrier layer to both sides of the mask so not only does it protect the wearer but also those around. By killing the virus on contact, it also means that the used face mask can be safely disposed of and not be a potential source of passive transfer.”
RMS shares have surged 25% to 0.75p following the announcement. However, its share price is down 46% for the year to date.
Remote Monitored Systems shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are RMS shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .